Group | Variables | Mean (DT) | Mean difference (DT) | |
---|---|---|---|---|
Control | PRI total | Initial (post surgery) | 30.59 (8.96) | − 2.24 (4.37) |
Final | 28.35 (7.61) | |||
FVC | Initial (post surgery) | 51.81 (11.14) | 7.86 (6.65) | |
Final | 59.68 (9.72) | |||
FEV1 | Initial (post surgery) | 55.00 (11.12) | 6.54 (5.59) | |
Final | 61.54 (9.56) | |||
Experimental | PRI total | Initial (post surgery) | 25.71 (12.42) | − 14.03 (8.71) |
Final | 11.69 (7.53) | |||
FVC | Initial (post surgery) | 56.66 (8.54) | 27.11 (14.07) | |
Final | 83.77 (14.04) | |||
FEV1 | Initial (post surgery) | 58.37 (9.72) | 28.68 (14.05) | |
Final | 87.06 (13.41) | |||
Placebo | PRI total | Initial (post surgery) | 26.92 (11.12) | − 4.05 (4.50) |
Final | 22.86 (9.33) | |||
FVC | Initial (post surgery) | 59.83 (11.14) | 8.34 (4.86) | |
Final | 68.17 (10.78) | |||
FEV1 | Initial (post surgery) | 63.54 (14.14) | 7.92 (8.07) | |
Final | 71.46 (11.40) |